Crossmark Global Holdings Inc. Has $6.05 Million Position in CIGNA Co. (CI)

Crossmark Global Holdings Inc. raised its holdings in CIGNA Co. (NYSE:CI) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 29,786 shares of the health services provider’s stock after purchasing an additional 379 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in CIGNA were worth $6,049,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of CI. Investec Asset Management LTD raised its position in CIGNA by 35.4% in the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock valued at $345,764,000 after purchasing an additional 483,904 shares during the last quarter. APG Asset Management N.V. raised its position in CIGNA by 148.4% in the 4th quarter. APG Asset Management N.V. now owns 670,299 shares of the health services provider’s stock valued at $113,367,000 after purchasing an additional 400,473 shares during the last quarter. Acadian Asset Management LLC raised its position in CIGNA by 80.8% in the 4th quarter. Acadian Asset Management LLC now owns 871,512 shares of the health services provider’s stock valued at $176,992,000 after purchasing an additional 389,590 shares during the last quarter. Bank of Montreal Can raised its position in CIGNA by 30.0% in the 4th quarter. Bank of Montreal Can now owns 1,232,172 shares of the health services provider’s stock valued at $250,243,000 after purchasing an additional 284,384 shares during the last quarter. Finally, PGGM Investments raised its position in CIGNA by 170.3% in the 3rd quarter. PGGM Investments now owns 348,572 shares of the health services provider’s stock valued at $65,162,000 after purchasing an additional 219,604 shares during the last quarter. Hedge funds and other institutional investors own 88.04% of the company’s stock.

Shares of CIGNA Co. (CI) opened at $195.44 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.39 and a current ratio of 0.37. CIGNA Co. has a 52 week low of $141.93 and a 52 week high of $227.13. The company has a market capitalization of $48,205.44, a price-to-earnings ratio of 18.91, a P/E/G ratio of 1.19 and a beta of 0.45.

CIGNA (NYSE:CI) last announced its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.07. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. The business had revenue of $10.53 billion during the quarter, compared to analysts’ expectations of $10.28 billion. During the same period in the previous year, the firm earned $1.87 earnings per share. The firm’s quarterly revenue was up 5.9% compared to the same quarter last year. analysts anticipate that CIGNA Co. will post 12.9 EPS for the current year.

In related news, EVP John M. Murabito sold 6,099 shares of CIGNA stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $220.10, for a total transaction of $1,342,389.90. Following the completion of the sale, the executive vice president now directly owns 68,026 shares of the company’s stock, valued at $14,972,522.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 212 shares of CIGNA stock in a transaction on Monday, December 11th. The stock was sold at an average price of $209.35, for a total value of $44,382.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 75,080 shares of company stock valued at $15,390,073. 1.30% of the stock is owned by insiders.

Several brokerages have issued reports on CI. Morgan Stanley lifted their price objective on CIGNA to $255.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Royal Bank of Canada reissued an “outperform” rating and issued a $220.00 target price (up from $185.00) on shares of CIGNA in a research note on Friday, November 3rd. Credit Suisse Group initiated coverage on CIGNA in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 target price for the company. Goldman Sachs Group initiated coverage on CIGNA in a research note on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 target price for the company. Finally, Oppenheimer lifted their target price on CIGNA to $237.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $210.12.

TRADEMARK VIOLATION WARNING: “Crossmark Global Holdings Inc. Has $6.05 Million Position in CIGNA Co. (CI)” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2018/02/08/crossmark-global-holdings-inc-has-6-05-million-position-in-cigna-co-ci.html.

CIGNA Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit